This page shows the latest inflammatory diseases news and features for those working in and with pharma, biotech and healthcare.
In December 2022, Pfizer launched a new company with Roivant Sciences to develop RVT-3101 for inflammatory and fibrotic diseases. ... The new company, which has been created to develop these programmes, will be fully responsible for funding global
Flavius Martin, executive vice president, research at Gilead, said: “Despite key advances over the past two decades, there remains significant unmet need for people living with inflammatory and autoimmune diseases. ... There are more than 100 chronic
inflammatory skin diseases due to the extreme itch it causes. ... 2 inflammation that plays a major role in multiple related and often co-morbid diseases.
Takeda has announced it will acquire Nimbus Therapeutics' NDI-034858, an oral, selective allosteric tyrosine kinase 2 (TYK2) inhibitor being evaluated for the treatment of multiple autoimmune diseases, in a deal ... the differentiation of this molecule
criteria’. Amgen will benefit from gaining several approved therapies as part of the deal, with Horizon’s pipeline of rare autoimmune and inflammatory disease drugs bolstering Amgen’s offering. ... strategy of delivering long-term growth by
Pfizer and Roivant Sciences have launched a new company focused on developing RVT-3101, a fully human monoclonal antibody targeting TL1A, for inflammatory and fibrotic diseases. ... Inflammatory bowel diseases, including UC and Crohn’s disease, affect
More from news
Approximately 7 fully matching, plus 166 partially matching documents found.
Similarly, at the Netherlands Heart Registry, a non-profit organisation facilitating a VBHC programme for cardiac diseases from 2015- 2017, the 120-day mortality for combined aortic valve disease and coronary ... Immune-mediated inflammatory diseases
oral treatments to treat patients with inflammatory bowel diseases. ... The company has been using artificial intelligence for the past eight years to help detect certain diseases such as cancer.
In the meantime, Sanofi is stepping up its focus in other areas like immunological and inflammatory diseases, rare blood disorders and vaccines, as well as cancer – an area it had been ... Meanwhile, Galapagos looks set to continue adding to its
Specifically, Hospira was selling Inflectra, an infliximab biosimilar used to treat several chronic inflammatory diseases, notably the inflammation of Crohn’s disease, while Pfizer was in an advanced stage of developing
Physicians need to be more aware of rare diseases that may hide behind recurring issues that some patients have. ... These are: Primary Immunodeficiency Diseases (PID – causes severe infections); Chronic Inflammatory Demyelinating Polyneuropathy (CIDP
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
He has 30 years’ experience in research and development specifically in gastrointestinal disorders, inflammatory diseases and cancers, and previously co-founded Synergy Pharmaceuticals and served as its chief scientific officer.
She has over 20 years of experience biomedical research and has focused on pathogenic mechanisms, underlying chronic inflammatory diseases and the interface between autoimmunity and cancer.
Dr Zhou will lead the team's discovery and engineering activities on Chimeric Antigen Receptor in Treg cells ( CAR-Treg) for immunotherapy of severe chronic autoimmune and inflammatory diseases and organ
Vedanta is advancing a pipeline of product candidates designed to treat autoimmune, inflammatory and infectious diseases using technology that mines the human microbiome for potent pharmaceutical products.
Atlantic's lead asset, alicaforsen for the treatment of the inflammatory bowel diseases ulcerative colitis and pouchitis.
More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.
FIDE joins other Expert Partnerships at FH including IHEP, which specializes in diseases of the liver and i-ONE, which specializes in oncology and hematology. ... We sat down with members of the FIDE Steering Committee to explore the latest key
Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology. ... About FIDE. FIDE is a full-service consultancy with extensive expertise in the
room, to the impact you’ve made on people’s lives with inflammatory diseases.
Overview of spondyloarthritis patient profiles and treatment pathways. Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including axial spondyloarthritis, psoriatic arthritis and akylosing spondylitis,
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...